Literature DB >> 16308251

Differentiating the cause of acute sensorineural hearing loss between Ménière's disease and sudden deafness.

Chun-Nan Chen1, Yi-Ho Young.   

Abstract

CONCLUSIONS: Most patients with Ménière's disease (MD) reveal abnormal vestibular-evoked myogenic potentials (VEMPs) and the recruitment phenomenon, whereas most sudden deafness patients display normal VEMPs without the recruitment phenomenon. We therefore recommend using both the recruitment phenomenon and VEMP testing as a diagnostic algorithm to differentiate between MD and sudden deafness as the cause of acute hearing loss.
OBJECTIVE: To recommend a diagnostic algorithm to differentiate between MD and sudden deafness as the cause of acute hearing loss.
MATERIAL AND METHODS: Between January 2002 and December 2003, 14 consecutive patients with "probable" MD who also had acute sensorineural hearing loss were enrolled in the study, together with another 14 age- and sex-matched patients with idiopathic sudden deafness. Each patient underwent a battery of audiovestibular function tests, including pure-tone audiometry, a stapedial reflex test, distortion-product otoacoustic emissions (DPOAEs), electronystagmography and a VEMP test. All patients were followed for at least 12 months after presentation.
RESULTS: Significant differences were found between MD and sudden deafness in terms of the recruitment phenomenon (86% and 21% of cases, respectively) and abnormal VEMP responses (71% and 21% of cases, respectively). However, the diseases did not differ significantly in terms of abnormal DPOAEs or caloric test results.

Entities:  

Mesh:

Year:  2006        PMID: 16308251     DOI: 10.1080/00016480510012363

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  9 in total

1.  Air- and bone-conducted vestibular evoked myogenic potentials (VEMPs) in otosclerosis: recordings before and after stapes surgery.

Authors:  M Trivelli; L D'Ascanio; M Pappacena; F Greco; F Salvinelli
Journal:  Acta Otorhinolaryngol Ital       Date:  2010-02       Impact factor: 2.124

2.  Association between Vestibular Function and Hearing Outcome in Idiopathic Sudden Sensorineural Hearing Loss.

Authors:  Ho-Seok Lee; Ji-Nam Song; Jung Mee Park; Kyoung Ho Park; Hyun Bum Kim; Jae-Hyun Seo
Journal:  Korean J Audiol       Date:  2014-12-22

3.  Clinical Characteristics and Short-term Outcomes of Acute Low Frequency Sensorineural Hearing Loss With Vertigo.

Authors:  Myung Jin Park; Sang Hoon Kim; Sung Su Kim; Seung Geun Yeo
Journal:  Clin Exp Otorhinolaryngol       Date:  2018-01-10       Impact factor: 3.372

4.  Association of αENaC p. Ala663Thr Gene Polymorphism With Sudden Sensorineural Hearing Loss.

Authors:  Jialei Chen; Jing He; Jing Luo; Shixun Zhong
Journal:  Front Genet       Date:  2021-12-22       Impact factor: 4.599

5.  Evaluation of the Recovery of Idiopathic Sudden Sensorineural Hearing Loss Based on Estimated Hearing Disorders.

Authors:  Tadashi Nishimura; Tadao Okayasu; Chihiro Morimoto; Sakie Akasaka; Tadashi Kitahara; Hiroshi Hosoi
Journal:  Audiol Res       Date:  2022-09-01

6.  Otoacoustic emissions value in patients with idiopathic sudden sensorineural hearing loss.

Authors:  Aya El-Sayed El-Sayed Gaafar; Elshahat Ibrahem Ismail; Hesham Saad Zaghloul
Journal:  J Otol       Date:  2022-06-23

Review 7.  Diagnostic Value of Vestibular Evoked Myogenic Potentials in Endolymphatic Hydrops: A Meta-Analysis.

Authors:  Sulin Zhang; Yangming Leng; Bo Liu; Hao Shi; Meixia Lu; Weijia Kong
Journal:  Sci Rep       Date:  2015-10-12       Impact factor: 4.379

8.  Vestibular Dysfunctions in Sudden Sensorineural Hearing Loss: A Systematic Review and Meta-analysis.

Authors:  Huiqian Yu; Huawei Li
Journal:  Front Neurol       Date:  2018-02-05       Impact factor: 4.003

Review 9.  Vestibular evoked myogenic potentials in the prognosis of sudden hearing loss ‒ a systematic review.

Authors:  Nathalia de Paula Doyle Maia; Karen de Carvalho Lopes; Fernando Freitas Ganança
Journal:  Braz J Otorhinolaryngol       Date:  2019-11-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.